GO:0045337 trans, trans-farnesyl diphosphate biosynthetic process: Isoprenoid Biosynthesis Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0045337 describes the enzymatic formation of 2-trans,6-trans-farnesyl diphosphate (FPP) from prenyl diphosphate precursors, a central node in isoprenoid biosynthesis.
FPP is the universal precursor for sesquiterpenes, sterols, dolichols, and prenylated proteins, making this process essential across all domains of life.
Prenyl chain elongating enzymes that produce FPP exhibit strict substrate and product specificity, determined by active-site residues.
Sesquiterpene synthases use FPP as a substrate and can cyclize it through cisoid or transoid pathways, linking GO:0045337 to specialized metabolism.
Dysregulation of FPP biosynthesis impacts cancer, neurodegeneration, and metabolic disorders through altered sterol and prenyl-protein production.
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of FPP biosynthetic enzymes in health and disease.

Description

trans, trans-farnesyl diphosphate biosynthetic process (GO:0045337) is the set of chemical reactions and pathways that produce 2-trans,6-trans-farnesyl diphosphate (FPP) from prenyl diphosphate precursors. FPP is a 15-carbon isoprenoid that serves as the branch-point metabolite for sterols, dolichols, ubiquinones, heme A, prenylated proteins, and thousands of sesquiterpenes. Because FPP sits at the intersection of primary and specialized metabolism, the enzymes that generate it are central to cell growth, membrane integrity, and signaling. Researchers study GO:0045337 to understand how organisms allocate carbon flux between competing isoprenoid outputs and how mutations in FPP-producing enzymes contribute to disease. The process is conserved from bacteria to plants to mammals, but the substrate specificities and product profiles of prenyltransferases differ substantially across species. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0045337, its genes, mechanisms, disease links, and experimental models.

trans, trans-farnesyl diphosphate biosynthetic process At A Glance

GO ID GO:0045337
GO term trans, trans-farnesyl diphosphate biosynthetic process
Ontology biological_process
Synonym farnesyl diphosphate anabolism; farnesyl diphosphate biosynthesis; farnesyl diphosphate biosynthetic process; farnesyl diphosphate formation; farnesyl diphosphate synthesis
Major function Production of 2-trans,6-trans-farnesyl diphosphate from prenyl diphosphate precursors
Substrate Prenyl diphosphate (e.g., DMAPP, GPP, IPP)
Product 2-trans,6-trans-farnesyl diphosphate (FPP)
Pathway context Mevalonate (MVA) and methylerythritol phosphate (MEP) pathways feed prenyl diphosphate precursors
Representative enzymes Farnesyl diphosphate synthase (FPPS), geranylgeranyl diphosphate synthase (GGPPS), and related prenyl chain elongating enzymes

What Is GO:0045337?

GO:0045337 is defined by QuickGO as the chemical reactions and pathways resulting in the formation of 2-trans,6-trans-farnesyl diphosphate from prenyl diphosphate. In practice, this means the stepwise condensation of isopentenyl diphosphate (IPP) with dimethylallyl diphosphate (DMAPP) and subsequent prenyl diphosphate intermediates to yield the 15-carbon trans,trans-farnesyl diphosphate product. The term is a biological_process and is synonymous with farnesyl diphosphate anabolism, biosynthesis, formation, and synthesis.

Why Is trans, trans-farnesyl diphosphate biosynthetic process Important in Cell Biology?

GO:0045337 is important because FPP is the central isoprenoid intermediate that feeds sterol biosynthesis, dolichol synthesis, protein prenylation, and sesquiterpene production. Any change in FPP flux can alter membrane composition, cell signaling, and specialized metabolite output, which has direct implications for cancer, neurodegeneration, and metabolic disease. Understanding the enzymes and regulatory logic of this process is therefore essential for both basic cell biology and therapeutic development.
FPP is the precursor for cholesterol and other sterols, making GO:0045337 central to membrane biology.
Dolichol biosynthesis depends on FPP, linking this process to protein N-glycosylation.
Protein prenylation (farnesylation) requires FPP and controls Ras, Rho, and other signaling proteins.
Sesquiterpene natural products in plants and microbes derive from FPP produced via this process.
Altered FPP flux is observed in cancer cells and can influence tumor growth and survival.
Neurodegenerative conditions may involve disrupted isoprenoid balance and prenylation.
Enzyme specificity in FPP synthesis is a target for metabolic engineering and drug discovery.
CRISPR models of FPP biosynthetic genes help establish causal roles in disease phenotypes.

What Happens During trans, trans-farnesyl diphosphate biosynthetic process?

Step 1: Supply of prenyl diphosphate precursors
In simple terms: The cell first makes small isoprenoid building blocks that will be joined together.
GO:0045337 begins with prenyl diphosphate substrates such as dimethylallyl diphosphate (DMAPP) and isopentenyl diphosphate (IPP), which are generated by the mevalonate or MEP pathways. These substrates are the raw material for chain elongation and are consumed by prenyltransferases that catalyze the biosynthetic process.
Step 2: Chain elongation to farnesyl diphosphate
In simple terms: Enzymes stitch the small building blocks together to make a longer 15-carbon molecule.
Prenyl chain elongating enzymes catalyze sequential condensation reactions that add IPP units to allylic prenyl diphosphate acceptors, ultimately producing the 15-carbon trans,trans-farnesyl diphosphate. Substrate specificities of these enzymes determine whether the product is FPP or a related prenyl diphosphate.
Step 3: Product release and partitioning
In simple terms: Once made, the FPP molecule is released and sent to different downstream pathways.
The FPP produced by GO:0045337 is released from the enzyme active site and partitioned into sterol, dolichol, ubiquinone, heme A, prenylated protein, or sesquiterpene pathways. In plants and microbes, sesquiterpene synthases can further convert FPP into diverse cyclic and acyclic products.
Step 4: Stereochemical and catalytic control
In simple terms: The enzyme controls the exact shape and stereochemistry of the product.
The biosynthetic process yields the 2-trans,6-trans stereoisomer of farnesyl diphosphate, and enzyme active-site residues enforce this specificity. Structural and mechanistic studies of prenyl chain elongating enzymes have revealed how substrate binding and catalysis are controlled.
Step 5: Downstream cyclization and diversification
In simple terms: The FPP product can be folded into many different ring-containing molecules.
Sesquiterpene synthases use FPP as a substrate and can cyclize it through cisoid or transoid pathways, generating the structural diversity of sesquiterpenes. This step links GO:0045337 directly to specialized metabolism and natural product biosynthesis.

Key Genes Involved in GO:0045337 trans, trans-farnesyl diphosphate biosynthetic process

The following genes and proteins are experimentally linked to trans, trans-farnesyl diphosphate biosynthetic process or its immediate downstream use, based on the verified literature.
GeneMajor RoleResearch Relevance
FPPS (farnesyl diphosphate synthase)Catalyzes formation of FPP from prenyl diphosphate precursorsCore enzyme of GO:0045337; target for metabolic and cancer studies
GGPPS (geranylgeranyl diphosphate synthase)Elongates prenyl diphosphates to longer productsSubstrate specificity studies inform FPP pathway engineering
Undecaprenyl diphosphate synthaseCis-prenyl chain elongating enzymeStructural model for prenyltransferase mechanism
Trichodiene synthaseSesquiterpene synthase using FPPSubstrate specificity and inhibition studies
Solanum habrochaites cis-prenyltransferasesShort-chain cis-prenyltransferasesResidues controlling substrate and product specificity
Plant sesquiterpene synthasesCyclize FPP into sesquiterpenesIn vivo sesquiterpene production in E. coli
2-fluorofarnesyl diphosphate-binding sesquiterpene synthaseCyclization pathway probeStructural elucidation of cisoid/transoid cyclization
Dolichol biosynthetic enzymesUse FPP for dolichol formationLinks GO:0045337 to glycosylation
Sterol biosynthetic enzymesConsume FPP for sterol productionMembrane and metabolic disease relevance
Protein prenyltransferasesUse FPP for farnesylationSignaling and cancer biology
Mevalonate pathway enzymesSupply prenyl diphosphate precursorsUpstream regulation of GO:0045337
MEP pathway enzymesAlternative precursor supplyPlant and microbial isoprenoid flux
IPP isomeraseConverts IPP to DMAPPPrecursor balance for FPP synthesis
Prenyl diphosphate synthase family membersChain elongationEnzyme specificity and engineering
Sesquiterpene synthase variantsFPP cyclizationNatural product diversity
Andrographis tissue-culture enzymesHydrolysis and isomerization of FPPPlant FPP metabolism

How Is trans, trans-farnesyl diphosphate biosynthetic process Regulated?

GO:0045337 is regulated at the level of precursor supply, enzyme abundance, and product demand. The mevalonate and MEP pathways determine the availability of prenyl diphosphate substrates, while feedback from sterol and non-sterol isoprenoid end products modulates flux through FPP-producing enzymes. In plants and microbes, sesquiterpene synthase expression can redirect FPP toward specialized metabolites. Enzyme active-site residues further regulate substrate and product specificity, providing a layer of catalytic control over the biosynthetic process.

trans, trans-farnesyl diphosphate biosynthetic process and Human Disease

GeneDisease / BiologyPotential Experimental Model
FPPSCancer and isoprenoid fluxKnockout and point-mutation cell lines
GGPPSPrenylation and metabolic diseaseOverexpression and knock-in models
Dolichol biosynthetic enzymesCongenital disorders of glycosylationKnockout and rescue models
Protein prenyltransferasesOncogenic signalingPoint-mutation and inhibitor studies
Sesquiterpene synthasesNatural product biosynthesisHeterologous expression in E. coli
Cancer and isoprenoid flux
Altered FPP biosynthesis affects the availability of substrates for protein prenylation and sterol synthesis, both of which are linked to cancer cell growth and survival. Because FPP is required for farnesylation of Ras and related proteins, changes in GO:0045337 can influence oncogenic signaling.
Neurodegeneration and prenylation
Disrupted isoprenoid balance can affect protein prenylation and membrane homeostasis in neurons, processes implicated in neurodegenerative conditions. FPP-derived dolichols are also required for N-glycosylation, which is essential for neuronal protein function.
Metabolic and glycosylation disorders
FPP is a precursor for dolichol, and defects in dolichol biosynthesis can lead to glycosylation disorders. This connects GO:0045337 to congenital disorders of glycosylation and related metabolic phenotypes.

From trans, trans-farnesyl diphosphate biosynthetic process-Related Genes to Experimental Models

Research QuestionSuitable Model
Is FPPS essential for FPP production?CRISPR knockout cell line
Which residues control substrate specificity?Point-mutation knock-in
Can a tagged enzyme be tracked in cells?Tagged knock-in
Does overexpression increase FPP flux?Overexpression cell model
How does FPP flux affect sterol synthesis?Knockout plus metabolic profiling
Can sesquiterpene output be redirected?Sesquiterpene synthase expression in E. coli

How to Study the trans, trans-farnesyl diphosphate biosynthetic process Process

MethodWhat It MeasuresTypical Application
Enzyme activity assayFPP formation from prenyl diphosphateSubstrate specificity
Crystal structureActive-site architectureMechanistic studies
Mass spectrometryIsoprenoid metabolite levelsFlux analysis
Heterologous expressionSesquiterpene productionPathway engineering
Site-directed mutagenesisResidue functionSpecificity determinants
Inhibition assaysEnzyme inhibitionSesquiterpene synthase studies
Cyclization pathway probesCisoid vs transoid foldingSesquiterpene synthase mechanism
Dolichol analysisDolichol biosynthesisGlycosylation studies
Enzyme activity assays
In vitro assays using prenyl diphosphate substrates measure the catalytic formation of FPP and define substrate specificity of prenyltransferases.
Structural biology
Crystal structures of prenyl chain elongating enzymes reveal active-site architecture and the basis for product chain length and stereochemistry.
Metabolic profiling
Mass spectrometry-based profiling quantifies FPP and downstream isoprenoids to assess flux through GO:0045337.
Heterologous expression
Expression of plant or microbial sesquiterpene synthases in E. coli enables in vivo production of FPP-derived sesquiterpenes.

How CRISPR Can Be Used to Study GO:0045337 trans, trans-farnesyl diphosphate biosynthetic process

Knockout

CRISPR knockout of FPPS or related prenyltransferases can abolish FPP production and reveal essential roles in sterol synthesis, prenylation, and cell viability.

Point Mutation

Point mutations in active-site residues of prenyl chain elongating enzymes can alter substrate and product specificity, helping map structure-function relationships in GO:0045337.

Knock-in

Knock-in of tagged or reporter alleles enables tracking of FPP biosynthetic enzymes in live cells and tissues.

Overexpression

Overexpression of FPPS or sesquiterpene synthases can increase flux through GO:0045337 and boost production of FPP-derived metabolites.

How EDITGENE Supports trans, trans-farnesyl diphosphate biosynthetic process Research

Researchers studying trans, trans-farnesyl diphosphate biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in FPP production, downstream isoprenoid flux, or disease phenotypes. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly.
Contact EDITGENE today to design your custom CRISPR model for trans, trans-farnesyl diphosphate biosynthetic process research.

Frequently Asked Questions About trans, trans-farnesyl diphosphate biosynthetic process

GO:0045337 is the Gene Ontology term for trans, trans-farnesyl diphosphate biosynthetic process, the formation of 2-trans,6-trans-farnesyl diphosphate from prenyl diphosphate.
Key genes include FPPS, GGPPS, and other prenyl diphosphate synthase family members, as well as downstream sesquiterpene synthases.
FPP is the precursor for sterols, dolichols, prenylated proteins, and sesquiterpenes, making it central to cell growth and metabolism.
Prenyl chain elongating enzymes such as farnesyl diphosphate synthase catalyze the condensation reactions that produce FPP.
It is regulated by precursor supply from the mevalonate and MEP pathways, enzyme abundance, and feedback from downstream isoprenoid products.
Altered FPP flux has been linked to cancer, neurodegeneration, and glycosylation disorders through effects on prenylation and dolichol synthesis.
Enzyme activity assays, structural biology, metabolic profiling, and heterologous expression are common approaches.
Knockout, point mutation, knock-in, and overexpression models can be generated for FPPS and related genes.
Yes, FPP is cyclized by sesquiterpene synthases into diverse sesquiterpenes through cisoid or transoid pathways.
The biosynthetic process yields the 2-trans,6-trans stereoisomer of farnesyl diphosphate.

Conclusion

GO:0045337 trans, trans-farnesyl diphosphate biosynthetic process is a central metabolic node that supplies FPP for sterols, dolichols, prenylated proteins, and sesquiterpenes. Its enzymes exhibit strict substrate and product specificity, and their dysfunction is linked to cancer, neurodegeneration, and glycosylation disorders. CRISPR-based knockout, point mutation, knock-in, and overexpression models provide powerful tools to dissect the causal roles of FPP biosynthetic genes in health and disease.

References

  1. 1. Mackie H et al.. 1977. Hydrolysis and isomerization of trans,trans-farnesyl diphosphate by Andrographis tissue-culture enzymes.. Eur J Biochem 77(1):101-6 PMID: 198206
  2. 2. Kang JH et al.. 2014. Determination of residues responsible for substrate and product specificity of Solanum habrochaites short-chain cis-prenyltransferases.. Plant Physiol 164(1):80-91 PMID: 24254315
  3. 3. Cane DE et al.. 1995. Trichodiene synthase. Substrate specificity and inhibition.. Biochemistry 34(8):2471-9 PMID: 7873526
  4. 4. Fujihashi M et al.. 2001. Crystal structure of cis-prenyl chain elongating enzyme, undecaprenyl diphosphate synthase.. Proc Natl Acad Sci U S A 98(8):4337-42 PMID: 11287651
  5. 5. Nagaki M et al.. 2004. Substrate specificities of several prenyl chain elongating enzymes with respect to 4-methyl-4-pentenyl diphosphate.. Biosci Biotechnol Biochem 68(10):2070-5 PMID: 15502351
  6. 6. Martin VJ et al.. 2001. The in vivo synthesis of plant sesquiterpenes by Escherichia coli.. Biotechnol Bioeng 75(5):497-503 PMID: 11745124
  7. 7. Noel JP et al.. 2010. Structural elucidation of cisoid and transoid cyclization pathways of a sesquiterpene synthase using 2-fluorofarnesyl diphosphates.. ACS Chem Biol 5(4):377-92 PMID: 20175559
  8. 8. Gough DP et al.. 1970. The characterization and stereochemistry of biosynthesis of dolichols in rat liver.. Biochem J 118(1):163-6 PMID: 4319540
Contact Us
*
*
*
*
How did you hear about us: